Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Case Study · July 23, 2023

CD19-Targeting CAR T-Cell Therapy for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome

JAMA: The Journal of the American Medical Association

 

Additional Info

JAMA: The Journal of the American Medical Association
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
JAMA 2023 Jun 27;329(24)2154-2162, AC Pecher, L Hensen, R Klein, R Schairer, K Lutz, D Atar, C Seitz, A Stanger, J Schneider, C Braun, M Schmidt, M Horger, A Bornemann, C Faul, W Bethge, J Henes, C Lengerke

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading